Awad Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 9.85 M
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
About Awad Sciences
Awad Sciences Private Limited (ASPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 January 2021 (Four years and one month 1 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 9.85 M, as per Ministry of Corporate Affairs (MCA) records.
Muralidhar Reddy and Vikas Saluguti serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304TG2021PTC147815
- Company No.
147815
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Awad Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Muralidhar Reddy  | Director | 18-Jan-2021 | Current |
| Vikas Saluguti | Director | 18-Jan-2021 | Current |
Financial Performance of Awad Sciences.
Enhance accessibility to Awad Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Awad Sciences?
Unlock access to Awad Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Connuct Lifesciences Private LimitedVikas Saluguti is a mutual person
Enthusis Technologies Private LimitedVikas Saluguti is a mutual person
Tailcurrent Technologies Private LimitedVikas Saluguti is a mutual person
Taneja Aerospace And Aviation LtdMuralidhar Reddy is a mutual person
Geny Medium Labs Private LimitedVikas Saluguti is a mutual person
Taal Tech India Private LimitedMuralidhar Reddy is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Awad Sciences?
Awad Sciences has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Awad Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Awad Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.